CN102895461A - Decoction medicine for treating liver-spleen disharmony type chloasma - Google Patents
Decoction medicine for treating liver-spleen disharmony type chloasma Download PDFInfo
- Publication number
- CN102895461A CN102895461A CN2012103578264A CN201210357826A CN102895461A CN 102895461 A CN102895461 A CN 102895461A CN 2012103578264 A CN2012103578264 A CN 2012103578264A CN 201210357826 A CN201210357826 A CN 201210357826A CN 102895461 A CN102895461 A CN 102895461A
- Authority
- CN
- China
- Prior art keywords
- medicine
- decoction medicine
- treatment
- spleen
- gram
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a Chinese medicinal preparation, i.e. a decoction medicine for treating liver-spleen disharmony type chloasma. The medicine is prepared from the following raw materials: 9-12g of white peony roots, 9-12g of bighead atractylodes rhizome, 6-7g of radix aucklandiae, 13-15g of Chinese yam, 15-18g of fiveleaf akebia fruits, and 15-18g of Trillium tschonoskii Maxim. The decoction medicine has the characteristics of low cost, easy preparation, small toxic and side effect, and good curative effect.
Description
Technical field:
The present invention relates to a kind of Chinese medicine preparation, i.e. a kind of become estranged decoction medicine of type chloasma of liver spleen for the treatment of.
Background technology:
Chloasma is commonly called as butterfly spot, is to betide facial a kind of chromatopathy, common women.Its cause of disease is comparatively complicated, and it is generally acknowledged may be relevant with endocrine.The become estranged Symptoms of type chloasma of liver spleen is: facial patch is LIPI color map shape, symmetry, and scope is larger, and greasy etc. in vain with distending pain over the hypochondrium, the vexed anorexia of gastral cavity, loose stool, tongue.At present, the become estranged medicine of type chloasma of state's internal therapy liver spleen is more, mainly take Western medicine as main, but has the shortcomings such as medical expense is high, therapeutic effect is satisfied not.
Summary of the invention:
The objective of the invention is to use the existing weak point of medicine for the present treatment liver spleen type chloasma of becoming estranged, and a kind of become estranged decoction medicine of type chloasma of liver spleen for the treatment of is provided.
Technical scheme of the present invention is achieved in that
A kind of become estranged decoction medicine of type chloasma of liver spleen for the treatment of, this medicine is made by following raw material: the Radix Paeoniae Alba, each 9-12 gram of the Rhizoma Atractylodis Macrocephalae, Radix Aucklandiae 6-7 gram, Rhizoma Dioscoreae 13-15 gram, Fructus Akebiae, each 15-18 gram of Rhizoma Trillii Tschonoskii.
A kind of become estranged decoction medicine of type chloasma of liver spleen for the treatment of, the preparation method of this medicine is: above-mentioned raw material of Chinese medicine is put into drug-decocting appliance marmite, crock or aluminum pot by proportional quantity, add clean water, amount of water was advisable to soak powder 2-3cm, decocted frontly to soak half an hour first, made raw material fully moistening, fully fried in order to medicine juice, then, boil with high heat, use again slow fire instead and decoct, when decocting about 20 minutes, be every dose and stop when frying in shallow oil into 180-200 milliliter medicine juice, the elimination medicinal residues, take concoction.
A kind of become estranged decoction medicine of type chloasma of liver spleen for the treatment of, the pharmaceutical formulation cost of material is cheap, and feeding is easy, can reduce medical expense, alleviates patient economy burden.
A kind of become estranged decoction medicine of type chloasma of liver spleen for the treatment of, its treatment thinking is soothing liver and strengthening spleen, blood-activating and qi-promoting.Follow the property of medicine through belonging at composition of raw materials, lay particular stress on soothing liver and strengthening spleen, take into account whole machine balancing.The Radix Paeoniae Alba has the nourishing blood to suppress the hyperactive liver effect in the medicine, the Rhizoma Atractylodis Macrocephalae has spleen reinforcing, stomach reinforcing, dampness and middle effect, the Radix Aucklandiae has warming middle-JIAO for easing the stomach, circulation of qi promoting effect, Rhizoma Dioscoreae has spleen invigorating, tonifying the lung, the smart effect of controlling nocturnal emission with astringent drugs benefit, Fructus Akebiae has depressed liver-energy dispersing and QI regulating, the effect of invigorating blood circulation, and Rhizoma Trillii Tschonoskii has the soothing liver-QI of dispeling the wind, the effect of invigorating blood circulation.Above-mentioned raw material of Chinese medicine is through dialectical compatibility, complements each other using, thereby effectively given play to soothing liver and strengthening spleen, the effect of blood-activating and qi-promoting, cures the become estranged purpose of type chloasma of liver spleen to reach.
The present invention has following features: cost is low, preparation is easy, toxic and side effects is little, curative effect is better.
Using method:
1, this medicine is the Orally-administered decoction medicine.
2, consumption: every day potion.Every dose of priority fries in shallow oil twice, with head fry in shallow oil, two fry in shallow oil the medicine juice fried in shallow oil for twice and merge after, take at twice.
3, medicine time: the upper and lower noon respectively once.Took medicine in two hours after the meal.
4, medicine temperature control: decoction being taken warmly.
The taboo item:
Fried sticky, the cold solid food hard, nondigestible and excitatory of period in a medicine taboo edible oil.
The specific embodiment:
Embodiment 1: a kind of become estranged material combination of decoction medicine of type chloasma of liver spleen for the treatment of is: the Radix Paeoniae Alba, each 9 gram of the Rhizoma Atractylodis Macrocephalae, the Radix Aucklandiae 6 grams, Rhizoma Dioscoreae 13 grams, Fructus Akebiae, each 15 gram of Rhizoma Trillii Tschonoskii.The preparation method of medicine is: above-mentioned raw material of Chinese medicine is put into drug-decocting appliance marmite, crock or aluminum pot by proportional quantity, add clean water, amount of water was advisable to soak powder 2-3cm, decoct and frontly soak half an hour first, make raw material fully moistening, fully fried in order to medicine juice, then, boil with high heat, use slow fire instead again and decoct, when decocting about 20 minutes, namely every dose stops when frying in shallow oil into 180-200 milliliter medicine juice, the elimination medicinal residues, take concoction.
Embodiment 2: a kind of become estranged material combination of decoction medicine of type chloasma of liver spleen for the treatment of is: the Radix Paeoniae Alba, each 12 gram of the Rhizoma Atractylodis Macrocephalae, the Radix Aucklandiae 7 grams, Rhizoma Dioscoreae 15 grams, Fructus Akebiae, each 18 gram of Rhizoma Trillii Tschonoskii.The preparation method of medicine is: above-mentioned raw material of Chinese medicine is put into drug-decocting appliance marmite, crock or aluminum pot by proportional quantity, add clean water, amount of water was advisable to soak powder 2-3cm, decoct and frontly soak half an hour first, make raw material fully moistening, fully fried in order to medicine juice, then, boil with high heat, use slow fire instead again and decoct, when decocting about 20 minutes, namely every dose stops when frying in shallow oil into 180-200 milliliter medicine juice, the elimination medicinal residues, take concoction.
Clinical therapeutic efficacy:
Experimentation: 2009 to 2011, adopt this technical scheme treatment liver spleen type patient with chloasma totally 15 examples of becoming estranged.Minimum 19 years old of patient age, maximum 54 years old, wherein 30-50 year patient 13 examples accounted for 86%.The shortest person of sick time 15 days, elder 24 months, wherein 12 routine sick times 15 days to 6 months between.By technique scheme treatment, every day potion, 12 days is a course for the treatment of, treating two courses for the treatment of is drug withdrawal.
Diagnostic criteria: a kind of become estranged decoction medicine of type chloasma of liver spleen for the treatment of, the disease for the treatment of, its symptom is defined as: facial patch is LIPI color map shape, symmetry, scope is larger, and greasy etc. in vain with distending pain over the hypochondrium, the vexed anorexia of gastral cavity, loose stool, tongue.
Curative effect judging standard: curative effect judges whether Main Basis disappears in this disease symptoms, specifically is divided into following three grades: recovery from illness---after the patient takes medicine, and all symptom complete obiterations of disease; Taking a turn for the better---after the patient took medicine, all symptom major parts of disease disappeared or obviously alleviate; Invalid---after the patient took medicine, all symptoms of disease had no to disappear.
Therapeutic outcome: with Drug therapy liver spleen of the present invention type patient with chloasma 15 examples of becoming estranged, 1 example of fully recovering in 10 days of taking medicine, 1 example of fully recovering in 11-12 days of taking medicine, 7 examples of fully recovering in 13-24 days of taking medicine, 6 examples took a turn for the better after two courses for the treatment of of taking medicine.Cure rate is that cure rate is 60% in 13%, two course for the treatment of in one course for the treatment of, and effective percentage is 100%.Sick time is 15 days 12 routine patients between to 6 months, after two courses for the treatment of of taking medicine, and 8 examples of fully recovering, cure rate is 66%; Sick time is 3 routine patients more than 6 months, after two courses for the treatment of of taking medicine, and 1 example of fully recovering, cure rate is 33%.Analyze thus, medicine of the present invention will be significantly better than the longer patient of the course of disease to the shorter patient treatment effect of the course of disease.
Claims (1)
1. treat the become estranged decoction medicine of type chloasma of liver spleen for one kind, it is characterized in that this medicine made by following raw material medicaments: the Radix Paeoniae Alba, each 9-12 gram of the Rhizoma Atractylodis Macrocephalae, Radix Aucklandiae 6-7 gram, Rhizoma Dioscoreae 13-15 gram, Fructus Akebiae, each 15-18 gram of Rhizoma Trillii Tschonoskii.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103578264A CN102895461A (en) | 2012-09-14 | 2012-09-14 | Decoction medicine for treating liver-spleen disharmony type chloasma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012103578264A CN102895461A (en) | 2012-09-14 | 2012-09-14 | Decoction medicine for treating liver-spleen disharmony type chloasma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102895461A true CN102895461A (en) | 2013-01-30 |
Family
ID=47568147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012103578264A Pending CN102895461A (en) | 2012-09-14 | 2012-09-14 | Decoction medicine for treating liver-spleen disharmony type chloasma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102895461A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104940455A (en) * | 2015-06-05 | 2015-09-30 | 包玲丽 | Traditional Chinese medicine for treating female chloasma |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1153655A (en) * | 1996-08-19 | 1997-07-09 | 侯永康 | Chinese medicine prepn for balancing internal secretion |
| CN1321439A (en) * | 2000-05-02 | 2001-11-14 | 陈江辉 | Compound spot-eliminating tea and its preparation method |
| CN101843821A (en) * | 2010-06-01 | 2010-09-29 | 廖万清 | Chinese medicinal composition for treating chromatosis and preparation thereof |
-
2012
- 2012-09-14 CN CN2012103578264A patent/CN102895461A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1153655A (en) * | 1996-08-19 | 1997-07-09 | 侯永康 | Chinese medicine prepn for balancing internal secretion |
| CN1321439A (en) * | 2000-05-02 | 2001-11-14 | 陈江辉 | Compound spot-eliminating tea and its preparation method |
| CN101843821A (en) * | 2010-06-01 | 2010-09-29 | 廖万清 | Chinese medicinal composition for treating chromatosis and preparation thereof |
Non-Patent Citations (2)
| Title |
|---|
| 徐灿坤等: ""黄褐斑的机理及辨证论治"", 《辽宁中医药大学学报》 * |
| 陈贵廷等主编: "《实用中西医结合诊断治疗学》", 31 July 1991 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104940455A (en) * | 2015-06-05 | 2015-09-30 | 包玲丽 | Traditional Chinese medicine for treating female chloasma |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101313962B (en) | Decoction medicament for treating impetigo | |
| CN101002872B (en) | Oral traditional Chinese medicine for treating anemic hemidrosis | |
| CN102895431A (en) | Oral Chinese medicine for treatment of intractable beriberi | |
| CN101327268B (en) | Oral chinese medicine for treating solar urticaria | |
| CN101306141B (en) | Decoction for treating qi-blood disharmony type vitiligo | |
| CN101199575B (en) | Chinese medicine agent for treating hand laced fir pellet | |
| CN102895461A (en) | Decoction medicine for treating liver-spleen disharmony type chloasma | |
| CN101301341A (en) | Decoction for treating acute eczema | |
| CN101301344B (en) | Oral Chinese medicine for treating blood-heat drug induced dermatitis | |
| CN101336977B (en) | Oral traditional Chinese medicine for treating channels blockage type vitiligo | |
| CN102743644B (en) | A kind of decoction medicine treating type of hyperactivity of heart-fire insomnia | |
| CN101306079B (en) | Decoction for treating poliomyelitis | |
| CN101306148B (en) | Traditional Chinese medicine orally taken for treating intractable psoriasis | |
| CN102824478A (en) | Decoction medicine for treating heart-spleen deficiency type insomnia | |
| CN101337027B (en) | Oral traditional Chinese medicine for treating kidney-water depletion type chloasma | |
| CN102872298A (en) | Decoction medicament for treating kidney and spleen deficiency type proteinuria | |
| CN102824534B (en) | A kind of decoction medicine for the treatment of yin-blood deficiency type nettle rash | |
| CN101199724B (en) | Oral administration Chinese medicine for treating liver stomach discord type hematemesis | |
| CN101347593B (en) | Decoction medicament for treating haematemesis induced by chronic gastritis | |
| CN102772742A (en) | Traditional Chinese medicine decoction for treating yin-deficiency epistaxis | |
| CN102895331A (en) | Chinese medicinal decoction for treatment of qi stagnation and blood stasis type alopecia areata | |
| CN102872193A (en) | Oral Chinese medicament for treating meridian blocking leucoderma | |
| CN101317889A (en) | Decoction medicament for treating pityriasis | |
| CN101199757A (en) | Oral administration Chinese medicine for treating yin deficiency toothache | |
| CN102872222A (en) | Chinese medicinal decoction for treating blood deficiency and wind dryness type alopecia areata |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20130130 |
|
| RJ01 | Rejection of invention patent application after publication |